268 related articles for article (PubMed ID: 20685357)
1. 4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway.
Zhang Y; Sano M; Shinmura K; Tamaki K; Katsumata Y; Matsuhashi T; Morizane S; Ito H; Hishiki T; Endo J; Zhou H; Yuasa S; Kaneda R; Suematsu M; Fukuda K
J Mol Cell Cardiol; 2010 Oct; 49(4):576-86. PubMed ID: 20685357
[TBL] [Abstract][Full Text] [Related]
2. 4-Hydroxynonenal induces Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes.
López-Bernardo E; Anedda A; Sánchez-Pérez P; Acosta-Iborra B; Cadenas S
Free Radic Biol Med; 2015 Nov; 88(Pt B):427-438. PubMed ID: 25843654
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3 kinase pathway and 4-hydroxy-2-nonenal-induced oxidative injury in the RPE.
Chen J; Wang L; Chen Y; Sternberg P; Cai J
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):936-42. PubMed ID: 18806289
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of 3H-1,2-dithiole-3-thione-induced glutathione, glutathione S-transferase and aldose reductase in protecting against 4-hydroxy-2-nonenal toxicity in cultured cardiomyocytes.
Li Y; Cao Z; Zhu H; Trush MA
Arch Biochem Biophys; 2005 Jul; 439(1):80-90. PubMed ID: 15946642
[TBL] [Abstract][Full Text] [Related]
5. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J
Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress.
Zhu H; Jia Z; Misra BR; Zhang L; Cao Z; Yamamoto M; Trush MA; Misra HP; Li Y
Cardiovasc Toxicol; 2008; 8(2):71-85. PubMed ID: 18463988
[TBL] [Abstract][Full Text] [Related]
7. Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2.
Katsumata Y; Shinmura K; Sugiura Y; Tohyama S; Matsuhashi T; Ito H; Yan X; Ito K; Yuasa S; Ieda M; Urade Y; Suematsu M; Fukuda K; Sano M
Hypertension; 2014 Jan; 63(1):80-7. PubMed ID: 24101662
[TBL] [Abstract][Full Text] [Related]
8. Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability.
Sha LK; Sha W; Kuchler L; Daiber A; Giegerich AK; Weigert A; Knape T; Snodgrass R; Schröder K; Brandes RP; Brüne B; von Knethen A
Free Radic Biol Med; 2015 Jun; 83():77-88. PubMed ID: 25687825
[TBL] [Abstract][Full Text] [Related]
9. Luteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells.
Wu PS; Yen JH; Kou MC; Wu MJ
PLoS One; 2015; 10(6):e0130599. PubMed ID: 26087007
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant effects of diallyl trisulfide on high glucose-induced apoptosis are mediated by the PI3K/Akt-dependent activation of Nrf2 in cardiomyocytes.
Tsai CY; Wang CC; Lai TY; Tsu HN; Wang CH; Liang HY; Kuo WW
Int J Cardiol; 2013 Sep; 168(2):1286-97. PubMed ID: 23453443
[TBL] [Abstract][Full Text] [Related]
11. Cinnamaldehyde protects cardiomyocytes from oxygen-glucose deprivation/reoxygenation-induced lipid peroxidation and DNA damage via activating the Nrf2 pathway.
Li YG; Li JH; Wang HQ; Liao J; Du XY
Chem Biol Drug Des; 2024 Feb; 103(2):e14489. PubMed ID: 38404216
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro.
Tanito M; Agbaga MP; Anderson RE
Free Radic Biol Med; 2007 Jun; 42(12):1838-50. PubMed ID: 17512463
[TBL] [Abstract][Full Text] [Related]
13. Z-ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro.
Peng B; Zhao P; Lu YP; Chen MM; Sun H; Wu XM; Zhu L
Brain Res; 2013 Jul; 1520():168-77. PubMed ID: 23688544
[TBL] [Abstract][Full Text] [Related]
14. Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions.
Ueda K; Ueyama T; Yoshida K; Kimura H; Ito T; Shimizu Y; Oka M; Tsuruo Y; Ichinose M
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G460-9. PubMed ID: 18617559
[TBL] [Abstract][Full Text] [Related]
15. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling.
Gao S; Yang Z; Shi R; Xu D; Li H; Xia Z; Wu QP; Yao S; Wang T; Yuan S
Eur J Pharmacol; 2016 May; 779():111-21. PubMed ID: 26973173
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion.
Xu Z; Cho H; Hartsock MJ; Mitchell KL; Gong J; Wu L; Wei Y; Wang S; Thimmulappa RK; Sporn MB; Biswal S; Welsbie DS; Duh EJ
J Neurochem; 2015 Apr; 133(2):233-41. PubMed ID: 25683606
[TBL] [Abstract][Full Text] [Related]
17. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2.
Chen ZH; Saito Y; Yoshida Y; Sekine A; Noguchi N; Niki E
J Biol Chem; 2005 Dec; 280(51):41921-7. PubMed ID: 16219762
[TBL] [Abstract][Full Text] [Related]
18. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells.
Ishikado A; Nishio Y; Morino K; Ugi S; Kondo H; Makino T; Kashiwagi A; Maegawa H
Biochem Biophys Res Commun; 2010 Nov; 402(1):99-104. PubMed ID: 20920477
[TBL] [Abstract][Full Text] [Related]
19. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart.
Chen J; Henderson GI; Freeman GL
J Mol Cell Cardiol; 2001 Nov; 33(11):1919-27. PubMed ID: 11708837
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells.
Pettazzoni P; Ciamporcero E; Medana C; Pizzimenti S; Dal Bello F; Minero VG; Toaldo C; Minelli R; Uchida K; Dianzani MU; Pili R; Barrera G
Free Radic Biol Med; 2011 Oct; 51(8):1610-8. PubMed ID: 21816220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
